BioSpace News Archive

The Gates Biomanufacturing Facility has announced the successful completion of the full cycle manufacturing of the recombinant Bulk Drug Substance of the anti-Tau vaccine, AV-1980R, in collaboration with the Institute for Molecular Medicine, California.

Mersana Therapeutics, Inc. announced that on November 1, 2022, an authorized sub-committee of the Compensation Committee of the Board of Directors of Mersana granted inducement awards, consisting of stock options to purchase an aggregate of 9,150 shares of its common stock and restricted stock unit awards to acquire an aggregate of 33,825 shares of its common stock, to 6 new employees whose employment commenced in October 2022.

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that it will participate in the Jefferies London Healthcare Conference in London, UK on Tuesday, November 15 at 3:50 PM GMT.

Atara Biotherapeutics, Inc., a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, reported the grant of 7,200 restricted stock units of Atara’s common stock to two newly hired employees.

Insulet Corporation, announced on October 17, 2022, a Medical Device Correction for all Omnipod DASH® Personal Diabetes Managers distributed globally.

Syros Pharmaceuticals, a leader in the development of medicines that control the expression of genes, announced the grant of restricted stock unit awards for an aggregate of 22,610 shares of Syros common stock to three newly hired employees in connection with their commencement of employment with Syros.

EMPA-KIDNEY phase III clinical trial met its primary endpoint by demonstrating a significant kidney and cardiovascular benefit for adults living with chronic kidney disease (CKD).

Aptabio will present Isuzinaxib Phase 2 clinical trial[1] results at the American Society of Nephrology (ASN)'s Kidney Week 2022 in Orlando, FL.

California Life Sciences, the state’s most impactful life sciences trade association, announced the winners of its 19th annual Pantheon Awards.

Oxurion NV announced that, pursuant to Belgian Transparency legislation1 it has received transparency notification following the issuance of new shares pursuant to the Capital Commitment entered into with Negma Group.